Julie D. Klapstein's Insider Trades & SAST Disclosures
Julie D. Klapstein's most recent trade in Amedisys Inc. was a trade of 1,690 Common Stock done . Disclosure was reported to the exchange on May 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Julie D. Klapstein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2025 | 1,690 | 16,031 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | D. Julie Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 7,356 | 15,634 | - | 0 | Class A common stock | |
| Amedisys Inc. | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,678 | 14,341 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 172,413 | 331,171 | - | 0 | Class A common stock | |
| NextGen Healthcare Inc | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 16.36 per share. | 22 Aug 2023 | 10,086 | 70,104 (0%) | 0% | 16.4 | 165,007 | Common Stock |
| Amedisys Inc. | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,941 | 12,663 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 106,382 | 158,758 | - | 0 | Class A common stock | |
| NextGen Healthcare Inc | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 9,483 | 60,018 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 1,304 | 10,722 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 22,271 | 52,376 | - | 0 | Class A common stock | |
| NextGen Healthcare Inc | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 11,459 | 50,535 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | Julie D. Klapstein | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 20 Aug 2021 | 12,000 | 30,105 | - | 6.0 | 71,957 | Class A common stock |
| Amedisys Inc. | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 574 | 9,418 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 11,723 | 18,105 | - | 0 | Class A common stock | |
| Claritev Corp. - Ordinary ... | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 6,382 | 6,382 | - | 0 | Class A common stock | |
| NextGen Healthcare Inc | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 11,837 | 39,076 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Julie D. Klapstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 851 | 8,844 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges